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1. Introduction 
The basic idea of Cognitive Behavioral Therapy (CBT) for depression (as well as for other 
disorders) is the intercorrelation of mood, thinking and behavior [1]. These three modalities 
are reciprocally correlated. That means that a negative mood can result in a reduced level of 
activity and a negative and constricted way of thinking but at the same time specific 
behaviors may lead to a bad mood and a negative way of thinking or one thought (or a bad 
memory) may narrow the behavior and depress mood.  
The first step of a successful CBT is to build up a good therapeutic relationship. In a second 
step, psychoeducation is followed by concrete therapy goals formulation. Within the next 
CBT sessions one of the central challenges for the therapist is to deduce the basic rationale of 
intercorrelation of mood, behavior and cognition from the personal experiences described 
by the patient and to illustrate how this interrelation may end up in a negative spiral. Thus, 
a rationale of depression has to be provided and the problems of the patient have to be 
related to this rationale. The main goal of CBT for depression is to stop the negative spiral 
and to initiate constructive changes on the behavioral as well as on the cognitive level. Thus, 
CBT undermines cognitive and behavioral maintenance factors of depression leading to re-
evaluations of underlying assumptions and beliefs so as to reduce vulnerability and risk 
factors [2].  
A first step to cause changes on the cognitive level, i.e. to reach cognitive restructuring, is to 
identify negative automatic thoughts the patient has in his/her everyday life as well as the 
cognitive biases that underlie these negative automatic thoughts. This may be for example 
‘all-or-nothing thinking’ or ‘emotional reasoning’. Within the CBT, cognitions are defined as 
hypotheses instead of being defined as facts and the patient is inspired to test these 
hypotheses. For this purpose therapists use the technique of Socratic dialogue. In a Socratic 
dialogue open questions are used to point out inconsistencies in the conclusions of the 
patient without devaluating, or showing up the patient. Questions therapists pose are short 
and concise, refer to proximate statements of the patient and are helpful to develop new 
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insights. If a cognition or thought has proven to be wrong alternative explanations and 
reattributions are developed together with the patient. Pros and Cons as well as short- and 
long-term consequences of specific attitudes are considered and weighed up.  
Besides these techniques that intend to reach cognitive restructuring, behavioral 
components are also part of the CBT for depression. These components aim to influence 
patient’s behavior directly, to provide immediate help, quick changes and facilitations, to 
increase positive experiences, as well as to overcome behavioral deficits. The main goals of 
the behavioral therapeutic elements are 1. to breach the vicious circle of inactivity, passivity, 
social withdrawal and depressive symptoms, 2. to structure everyday life and the course of 
specific actions and behaviors, 3. to interrupt and detract from rumination, 4. to acquire new 
skills and resources to reduce depressive behaviors and relapses, and 5. to support the 
cognitive interventions by the use of role plays, the enhancement of positive activities, and 
behavioral exercises that can be understood as experiments and reality testing [1].  
One of the first behavioral therapeutic elements that are used in the therapy of depression is 
the enhancement of positive activities alongside a reduction of negative activities as this 
allows for early positive experiences and positive reinforcements in the context of the 
therapy. Often, weekly activity schedules are used for this purpose, so that patients can 
record their activities. To vividly illustrate the association between behavior and mood 
patients are often asked to also record how they feel after the different activities they 
display. On this background the motivation to include more positive activities into the 
weekly activity schedule can be build up. 
Another behavioral therapeutic component is the improvement of social competences. The 
number of social contacts of depressed patients is often low and social competences of the 
patients are impaired. Consequently, social relationships of depressed patients are often not 
satisfactory. In many cases it does not suffice just to reduce the depressive symptomatology 
to overcome the reduced social contacts or the deficient social competences of the patients. 
Therefore, the improvement of social competences, communication skills and problem 
solving skills is an essential part of a promising CBT. The basic instruments in this context 
are the role play, behavioral exercises and the inclusion of partners and family members.   
Within the last therapy sessions of a CBT it is important to address the issue of relapse and 
recurrence of depression. After CBT, patients should be enabled to get along with future 
depressive symptoms, crises and possible relapses. Therefore, patients need to repeat and 
practice what they have learned thoroughly so as to be able to use all the techniques on their 
own after the CBT has been finished. Probable crises should be brought up to reflect 
possibilities to get along self-directed. Therefore, all materials that have been used in the 
therapy should be handed out to the patient so that he/she can use them as utilities. 
Furthermore, to prevent relapses it has proven to be helpful to fade out therapeutic contacts 
slowly by extending the time interval between the therapy sessions. This enables the 
therapist to be available for at least one year in case of crises or relapses after the main part 
of the therapy has been finished. Many patients value the offering of the so-called booster-
sessions. 
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2. Effectiveness and efficacy of cognitive behavioral therapy in the 
treatment of depression 
Placebo-controlled studies that compared the efficacy of cognitive behavior therapy (CBT) 
with that of antidepressant medication (ADM) found out that CBT is as efficacious as ADM 
in the treatment of patients with mild to severe forms of depression and that both 
treatments are superior to placebos [3-5]. Spoken numerically, about 40-60% of the patients 
respond to a CBT treatment [6]. However, early studies concluded that ADM is superior to 
pill-placebo in the treatment of severe depressions whereas CBT is not [7]. Even though this 
conclusion was mainly based on one study it had a great impact on the perception of 
treatment effectiveness and resulted in suggestions from the American Psychiatric 
Association that ADM should be preferred over CBT for patients with more severe forms of 
depression [8]. Yet, subsequently conducted studies found out that this conclusion was 
wrong and that CBT fares as well as ADM with severely depressed patients [4, 9]. 
Accordingly, ADM should not be considered to be superior to CBT for the acute treatment 
of severe forms of depression. However, it seems as if the efficacy of CBT in the treatment of 
severe forms of depression depends on a high level of therapist experience [4, 10]. 
Going beyond the immediate effects of ADM and CBT it has to be kept in mind that while 
medication usually has a rapid and robust effect it has been shown to prevent the return of 
depressive symptoms only for as long as it is taken [8]. Thus, the intake of medication does 
not seem to alter the risk factors that lead to a subsequent recurrence. For that reason 
medication does not reduce the risk of relapse once its use is terminated [11]. That is why 
most patients with chronic or recurrent forms of depression are encouraged to stay on 
medication for an indefinite period [6]. In contrast, CBT appears to have an enduring effect 
that reduces risk of relapse not only during the time of therapy but also after treatment 
termination [11-12]. In a meta-analysis of Gloaguen and colleagues it has for example been 
shown that the one-year relapse rate for patients previously treated with CBT was 
approximately 25%, whereas 50% of patients previously treated with ADM relapsed in the 
same period. Furthermore, it has been shown that the preventative effect of prior CBT is at 
least as large in magnitude as that effect that is produced by keeping patients on medication 
[13-14]. A combination of CBT and medication holds the benefits of each and thus may 
enhance the probability of treatment response over a monotherapy, especially in chronic 
depressions [11].  
Despite lower relapse rates associated with CBT as compared to medication relapse is still a 
substantial problem in CBT of depression. In contrast to addictive disorders where the focus 
has already many years ago been laid on relapse prevention research has not paid a lot of 
attention to relapse-prevention in depressive disorders. Patients who have recovered from 
recurrent major depressive disorder face an 80% rate of recurrence if they do not get further 
prophylactic treatment [15]. To handle and reduce that risk physicians prescribe either 
continuation- or maintenance-phase medication. In contrast, it still doesn’t seem to be 
custom to offer psychotherapeutic relapse-prevention after patients responded to the acute 
phase of depression-specific psychotherapeutic treatments. One concrete suggestion for 
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improving the long-term outcome of depressive patients after a CBT comes from Jarrett and 
colleagues who suggest to include a continuation or maintenance phase into the CBT [16]. 
Over an 8-month period the authors found that a CBT including a continuation phase (C-
CT) reduced relapse estimates significantly more than a control condition that was defined 
as evaluation without CT (10% vs. 31%). Over a 2-year follow-up, also including a CBT-free 
period, C-CT significantly reduced relapse and recurrence estimates in patients with early-
onset depression (16% vs. 67% in control). Furthermore, if patients had unstable remission 
during the late phase of acute treatment, C-CT also significantly reduced relapse and 
recurrence estimates to 37% as compared to 62% in the control group. Thus, the authors 
conclude that risk factors influence the necessity for relapse-prevention. In the 12-month 
follow-up of another study that has been conducted by DeRubeis and colleagues it has been 
found that patients who completed the CBT and had up to three optional booster sessions 
afterwards were significantly less likely to relapse than patients who switched to placebo 
after the acute phase CBT (31% vs. 76%) [4, 13]. Another promising way to reduce relapse-
rates seems to be mindfulness-based cognitive therapy (MBCT) that is designed to train 
recovered patients with recurrent depression to disengage from depressogenic thinking that 
may mediate relapse. Teasdale and colleagues reported that recovered patients who 
received treatment as usual (TAU) and MBCT instead of TAU alone had significantly lower 
relapse rates – however this was only the case for patients with three or more previous 
depressive episodes [17].    
CBT is not only effective in the treatment of acute depression and in relapse-prevention but 
also in the treatment of residual depressive symptoms. The largest study to date that 
addressed this issue included 158 patients with residual symptoms after a recent depressive 
episode that has been treated with ADM [18-19]. These patients either received clinical 
management alone or clinical management plus cognitive therapy over twenty weeks with 
two subsequent booster sessions. Patients received continuation and maintenance 
medication. CBT reduced relapse rates (29% vs. 47% in the clinical management group) as 
well as persistent residual symptoms. CBT also increased full remission rates at 20 weeks. 
Furthermore, the addition of CBT produced improvements in social and psychological 
functioning. 
In contrast to CBT there is only little knowledge concerning the long-term efficacy of other 
psychosocial treatments in relation to that of CBT. One study that aimed to test the theory of 
change that underlies CBT undertook a component analysis of CBT [20] and thereby treated 
patients either exclusively with behavioral activation (BA), a combination of BA and 
teaching of skills to modify automatic thoughts (AT), or the full CBT treatment also 
including the components that focus on core schema. Jacobson and colleagues [20] did not 
find an evidence that the complete CBT was superior to either component treatment – 
neither at the termination of acute treatment nor at the 6-month follow-up. Moreover, both 
BA as well as AT also altered negative thinking and dysfunctional attributional styles of the 
patients – just as did the complete CBT treatment. Another study even demonstrated that an 
expanded BA model was as effective as was ADM with respect to the reduction of acute 
distress of depressed patients independently of the level of initial depression severity, and 
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superior to CBT when regarding more severely depressed patients [21]. In a more recent 
randomized controlled trial of interpersonal psychotherapy (IPT) versus CBT it has been 
shown that even though patients in a treatment as usual condition improve just as do 
patients in a CBT or an IPT condition, IPT and CBT seem to be superior to TAU in at least 
some analyses [22]. Another study that aimed to compare the efficacy of interpersonal 
psychotherapy (IPT) and CBT demonstrated that both therapies are effective in treating 
depressive disorders, but that CBT seems to be superior in treating severe depression [23]. 
In contrast, de Mello and colleagues who conducted a systematic review of research 
findings on the efficacy of IPT for depressive disorders came to the conclusion that CBT is 
less efficacious than IPT [24].  
When searching for the effect size associated with CBT for depression the picture gets less 
homogenous compared to the question if CBT has an effect at all. CBT has been reported to 
have a medium effect size (d = .67) relative to a number of different control conditions as for 
example non-specific controls or the absence of treatment [25]. As expected the effect size of 
CBT is larger when it is compared to waiting list controls (d=0.88) than when it is compared 
to treatment as usual (d=0.38) or non-specific controls (d=0.38) [25]. Moreover, a 
combination of CBT with ADM seems to be superior to ADM alone as it is associated with a 
somewhat larger effect size (d=0.27). In an older meta-analysis Cuijpers, van Straten, 
Andersson and van Oppen [26] included 53 studies in which seven types of psychotherapy 
have been compared with other psychological treatment to examine the efficacy of 
psychotherapies for depression in adults. The authors concluded that all forms of 
psychotherapy were efficacious in treating depression. However, it seemed as if IPT was 
somewhat more efficacious (d = 0.20) whereas non-directive supportive treatment was 
somewhat less efficacious (d = -0.13) than the other treatments. Furthermore, it has been 
reported that the efficacy of group CBT (d= 0.15) does not significantly differ from the 
efficacy of individual CBT [27]. However, it has to be mentioned that the quality of the 
studies that have been included in the respective meta-analysis was rather low. In a more 
recent meta-analysis Cuijpers and collaborators [28] found evidence that the effects of 
psychotherapy for depression have been overestimated in former meta-analyses and that 
the quality of the studies examining psychotherapy for depression is associated with the 
effect sizes that have been found. Accordingly, they reported a standardized mean effect 
size of d = 0.22 for high quality studies as compared to a mean effect size of d = 0.74 in 
lower-quality studies, even after controlling for the control condition used. This difference 
has been significant. That lower study quality seems to be related with larger effect sizes has 
also been confirmed by a more recent review [29]. Moreover, Cuijpers and collaborators [30] 
found that in dependence of the kind of instrument used to measure improvement 
following a psychotherapy the effect sizes of studies examining the effect of psychotherapy 
for depression differ significantly so as to clinician-ratings are associated with a significantly 
greater effect size than are self-report measures. This has to be kept in mind when drawing 
conclusions from efficacy-studies.  
Besides the efficacy of CBT in sense of recovery and relapse-prevention that is at least 
comparable with or even superior to the efficacy of ADM it is important to mention that 
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CBT is also more cost-effective than ADM in the longer term [31]. And not only the efficacy 
of individual CBT has been well-documented but there are also hints that group CBT seems 
to be efficacious. In this context Brown and colleagues [32] compared the clinical 
effectiveness, costs, treatment preference, attrition and patient satisfaction of group and 
individual CBT in a naturalistic clinical study. Despite the fact that patients preferred 
individual CBT at baseline, they found no significant differences between group and 
individual CBT in depressive and distress symptoms at post-treatment and at 3-month 
follow-up. Furthermore, there were no differences in attrition and satisfaction between the 
two groups. However, the cost-effectiveness was higher for group CBT. Thus, if this finding 
holds true in further studies, it could be considered more frequently to conduct group CBT 
instead of individual CBT. 
3. Mediators and moderators of treatment effects of CBT for depression 
During the last years the search for moderators and mediators of the response to cognitive 
behavioral treatments for depression has been intensified. The reason therefore is that not 
only the response rate could be increased but also the costs could be decreased if we knew 
which patients are likely to respond to a CBT treatment and which processes mediate the 
treatment response. A moderator can be understood as a patient characteristic that is 
present before the treatment and independent of treatment assignment. Furthermore, it has 
an interactive effect with the treatment condition on the treatment outcome. Thus, a 
moderator variable influences the direction or the magnitude of the relationship between 
the independent (treatment condition) and the dependent (outcome) variable. It is important 
to distinguish between moderator variables that predict differential response to treatment 
and prognostic factors that predict the outcome in general and irrespective of treatment 
assignment [33]. In contrast, a mediator variable is an intervening variable that accounts for 
the relationship between the independent and the dependent variable. Thus, a mediator 
variable changes due to the treatment and in turn correlates with treatment outcome [33]. In 
the following section we would like to highlight the main findings concerning moderator 
and mediator variables of CBT for depression (without drawing a claim on completeness as 
there are several studies in this field even though the number is small as compared to 
studies examining moderators and mediators of ADM).  
While during the last years the search for possible moderators of the response to CBT 
treatment for depression has especially focused on the neurobiological activity pattern of the 
patients, it has already taken other variables into account long before.  
Some patient characteristics with unclear status: Prognostic factors or moderator variables for the 
response to CBT for depression? 
An early study of Sotsky et al. [34] in which 239 patients with a depressive disorder have been 
included has highlighted that six patient characteristics as well as the severity of the 
depression patients reported before the beginning of the treatment predict treatment outcome 
(not only of CBT but also of IPT, ADM with clinical management, and placebo with clinical 
management). These characteristics comprised social dysfunction, cognitive dysfunction, 
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expectation of improvement, endogenous depression, double depression and the duration of 
the current episode. Partly, these findings have been confirmed by Carter and colleagues who 
also found that a treatment response to either CBT or IPT is predicted by the perceived 
logicalness of the therapy (which conforms to the predictive value of the afore mentioned 
expectation of improvement), recurrent depression, and childhood reasons for the depression 
[35]. Furthermore, Fournier and colleagues found that older age and chronic depression 
predict relatively poor outcome following CBT as well as following ADM [36]. Uncontrolled 
pre-post-studies revealed that being married and displaying a lower initial symptom severity 
are prognostic of better response to CBT [37-38], however, it is unclear whether this finding is 
treatment-specific. Furthermore, patients who are above average intelligent seem to be more 
suitable for CBT than patients with lower intelligence [36, 39].  
In the last decades it has also been paid attention to the role of negative cognitive schemata 
in moderating the effect of CBT. Thereby, it has been assumed that having particular 
negative cognitive schemata leads to severe and chronic problems that are not changeable 
with standard CBT and therefore require specific schema-focused procedures [40]. Halford 
and colleagues examined if this hypothesis holds true for patients with depression or 
anxiety disorder and found that contrary to this assumption a greater initial endorsement of 
maladaptive schemata did not predict poor therapy response [41]. Again, it is unclear to 
date whether the endorsement of maladaptive schemata would also be associated with good 
treatment response to other psychosocial interventions. Thus, it remains unclear if this is a 
prognostic factor rather than a moderator variable.   
Another variable that has repeatedly been examined is the tendency to ruminate or to 
distract in response to depressed mood. In this context Teismann and colleagues found that 
even after controlling for depression scores pretreatment greater symptom- and self-focused 
rumination pretreatment predicts more self- and interviewer-rated depression as well as 
greater general symptom severity and lower therapists’ appraisal of success posttreatment 
[42]. However, in another study the same authors found that ruminative responses to 
depressed mood are neither predictive of the therapeutic alliance nor of patients’ receptivity 
to therapeutic interventions as perceived by the therapist [43]. Moreover, while the 
pretreatment tendency to distract was not associated with posttreatment depression after a 
CBT another study found that it is predictive of the patients’ receptivity in therapy and the 
goodness of the therapeutic alliance [42, 44]. Again, it is not clear whether these findings are 
specific to CBT or also hold true for any other psychosocial treatment.  
As it has been described before, during a CBT patients are taught to interrupt automatic 
emotional processing (e.g., rumination) with controlled processing (e.g., cognitive 
reappraisal). Accordingly, what a CBT seems to directly address is the sustained emotional 
reactivity that has repeatedly been associated with depression [45]. Furthermore, it has been 
shown that depression is associated with an increased and sustained reactivity in brain 
regions responsible for emotional processing, particularly the amygdala [46-48]. On this 
background Siegle, Carter and Thase [49] developed the idea that there might be an 
association between the neural correlates of sustained emotional processing pretreatment 
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and the posttreatment recovery. To test for this hypothesis, the authors subjected their 
participants to undergo an fMRI during an emotional information processing task before 
they received a CBT. The authors highlighted that a stronger recovery following a CBT was 
associated with a decreased reactivity to negative words in the subgenual cingulate cortex 
and an increased reactivity in the amygdala – both pretreatment. The authors suppose that 
the pattern of decreased reactivity in the subgenual cingulate cortex in combination with the 
sustained amygdala reactivity to emotional stimuli reflects a ruminative coping style. 
Indeed, the patients’ percent change in sustained amygdala activity was correlated with the 
self-reported tendency of the patients to ruminate, i.e., to think repetitively about their 
depressive symptoms. Accordingly, the authors suggest that their findings demonstrate that 
those patients benefit most from CBT who show an increased emotional reactivity 
pretreatment and who are not able to engage regulatory structures pretreatment. According 
to Siegle, Carter and Thase the latter has been illustrated by the decreased reactivity in the 
subgenual cingulated cortex pretreatment which suggests a deficient regulation. So, the 
authors conclude that the presence of emotion regulation deficits, which are targeted in 
CBT, may be the key to recovery with this specific intervention.  
Findings concerning more “severe and complicated patients” 
There are some preliminary indications that especially in the treatment of more severe and 
complicated patients a greater expertise of therapists is required to reach a successful 
outcome. In this context it has been shown that among patients with more severe 
depression, who are functionally impaired and have primary support group problems, both 
BA as well as ADM seem to be superior to pill-placebo whereas CT does not [21]. 
Furthermore, in another study the personality disorder status of the patients included led to 
differential response: In this study CT was superior to ADM for patients without personality 
disorder whereas the reverse was true for patients with personality disorder. However, 
despite the poor response of patients with comorbid Axis II disorders to CT, nearly all 
patients who did respond to CT within this study sustained their response over a one-year 
follow-up [50]. On the background of these studies Coffman and colleagues [51] concluded 
that “there might be a subset of patients who see themselves as doing better with sustained 
attention to behavior change in time-limited treatment”. However, as the authors correctly 
indicate, before drawing firm conclusion, this pattern of self-reported non-response to CT 
should be replicated. Interestingly, other studies that did only focus on increased comorbid 
personality disorder symptoms instead of diagnosed Axis II disorders found a reverse 
pattern: For example Carter and colleagues found that increasing comorbid personality 
disorder symptoms where associated with decreases in response to IPT but not to CBT [35]. 
Other studies have shown that CBT seems to be more effective for patients who display an 
elevated level of avoidant personality disorder symptoms whereas IPT seems to be superior 
for patients displaying an elevated level of obsessive-compulsive personality disorder 
symptoms [52]. Facing these rather heterogeneous findings concerning the influence of Axis 
II symptoms and Axis II disorder status on the response to CBT and other psychosocial 
treatments it gets clear that future investigations are needed to elucidate if this really can be 
understood as a moderator variable and if so if it is associated with higher or lower response 
rates to CBT. 
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In a more recent, prospective, randomized, observer blinded multicenter study Stangier and 
colleagues compared the rates of relapse in 180 completely remitted depressed patients with 
three or more previous episodes who either received TAU plus Maintenance Cognitive 
Therapy (MCT) or TAU plus Manualized Psychoeducation (MAPE) for eight months [53]. 
Afterwards the patients were followed up for one year. The authors found that time to 
relapse of MDE did not differ significantly between the two treatment conditions. However, 
there was a significant interaction between treatment condition and the number of previous 
MDE episodes (<5 vs. ≥5), indicating that in patients with 5 or more previous episodes MCT 
was significantly superior to MAPE, whereas this was not true for patients with less than 5 
previous episodes. The authors conclude that CBT has significant effects on relapse 
prevention only in patients with a high risk of depression recurrence whereas for patients 
with a lower risk of recurrence, non-specific and structured education may be equally 
effective.  
Some moderating patient characteristics 
Some patient characteristics examined in the early Sotsky study [34] have been predictive 
for differential treatment outcome. For instance, a low social dysfunction predicted superior 
response to IPT while a low cognitive dysfunction predicted superior response to CBT and 
to ADM. In addition, high depression severity and impairment of function have been 
associated with a superior response to ADM and IPT while high work dysfunction 
predicted superior response only to ADM.  
Fournier and colleagues found that marriage, unemployment, and having experienced a 
greater number of recent life events predict superior response to CBT as compared to ADM 
[36]. Interestingly, in another study Barber and Muenz found that married patients did 
better with CBT than they did with IPT whereas unmarried patients did better with IPT than 
with CBT [52].  
Patient’s “attachment avoidance” has been shown to be associated with a better response to 
CBT as compared to IPT [54]. Keeping in mind that CBT does not target close relationships 
as specifically as does IPT this result seems to be intuitive because one would expect that 
CBT should be less threatening to individuals with high attachment avoidance as compared 
to IPT. Furthermore, it has been reported that while avoidant and schizoid symptoms 
predicted poorer response to IPT this was not true for CBT [55].  
Another variable that was assumed to interact with treatment group to differentially affect 
treatment outcome is the patients’ preference concerning the intervention [56]. Kocsis and 
colleagues found that in a randomized multicenter trial that compared the efficacy of 
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) with that of nefazodone 
or the combination of both for chronic depression there was an interactive effect of the 
treatment preference of the patients (as indicated at study entry) and treatment group on the 
outcome. Patients who preferred medication at study entry had a higher remission rate and 
a lower symptom severity at study exit if they received medication than if they received 
CBT. Similarly, patients who preferred CBASP had a higher remission rate and a lower 
symptom severity at study exit if they received CBASP than if they received medication. 
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Thus, it can be concluded that patients’ preference is a significant moderator of treatment 
response for chronically depressed patients. However, Leykin and colleagues, who also 
compared treatment outcomes of patients who received their preferred treatment via 
randomization versus those who did not, did not find a significant difference in the 
magnitude of symptom reduction between these two groups [57]. As did Kocsis and 
colleagues, Leykin and colleagues compared ADM with CBT – however, they did not 
specifically focus on chronically depressed patients.  
The mediating role of neural mechanisms 
Hence, as a primary goal of CBT is the replacement of automatic emotional reactivity with 
more controlled processing it can be assumed that on the neural level CBT might be 
accompanied by an increase of inhibitory executive control that helps to dampen automatic 
reactions that are reflected in an increased limbic activity. Indeed, recent studies have shown 
that CBT affects clinical recovery by modulating the functioning of specific sites in cortical 
and limbic regions. For example Goldapple and colleagues [58] conducted a resting state 
positron emission tomography (PET) study and found that treatment response following a 
CBT is associated with increases in the metabolic activity of the hippocampus, and the 
dorsal cingulate cortex alongside decreases in the metabolism of the dorsal, ventral, and 
medial frontal cortex. This study, regarded on the background of older studies that 
examined the effects of ADM [59-60], suggests that while ADM effects may be targeted to 
limbic regions and then forwarded CBT may rather target the prefrontal cortex by 
downtuning cognitive processes that take place automatically. This is also assumed by 
DeRubeis, Siegle and Hollon [61] in a comprehensive review of treatment outcomes and 
neural mechanisms of CT and ADM for depression. Furthermore, in a randomized 
controlled trial Kennedy and colleagues [62] have shown that a treatment response to CBT 
as well as a treatment response to ADM (venlafaxine) are associated with decreased glucose 
metabolism bilaterally in the orbitofrontal cortex and left medial prefrontal cortex alongside 
an increase in the metabolism of the right occipital-temporal cortex. However, metabolic 
changes in the anterior and posterior parts of the subgenual cingulate cortex and the 
caudate differentiated CBT and venlafaxine responders. Thus, the authors conclude that 
while response to either treatment was associated with a reduced metabolism in several 
prefrontal regions, only response to CBT seems to be associated with a reciprocal 
modulation of cortical-limbic connectivity.  
Looking at further studies using functional neuroimaging techniques it gets obvious that 
different mediating brain mechanisms have been suggested and underpinned by single 
studies. One prospective study that included 16 medication-free patients suffering from an 
acute major depressive disorder has been conducted by Fu and colleagues [63]. During an 
fMRI scan pre- and posttreatment subjects performed an affect recognition task with 
morphed facial stimuli displaying sadness. In between patients received 16 CBT sessions. 
Pretreatment it has been shown that during the acute phase patients show an elevated 
amygdala-hippocampal activity as compared to healthy controls. At the end of the 
treatment the amygdala activity of the CBT responders has decreased to healthy niveau. 
Furthermore, the clinical response of the patients was significantly correlated with their 
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baseline dorsal anterior cingulate activity. Thus, the authors suggest that anterior cingulate 
activity may be a predictor of treatment response to CBT. In a more recent study Ritchey 
and colleagues also used fMRI to assess neural responses to negative, neutral, and positive 
pictures in healthy controls and unmedicated, depressed patients – the latter pre- and 
posttreatment [64]. As did the study described before, the authors of this study also found 
evidence that the neural differences between depressed patients and healthy controls during 
emotion processing can be successfully addressed by CBT. Prior to the treatment the authors 
found that depressed patients show a reduced activity in the ventromedial prefrontal cortex, 
a diminished discrimination between emotional and neutral stimuli in the amygdala, 
caudate and hippocampus and an increased reactivity to negative versus positive pictures in 
the left anterior temporal lobe and the right dorsolateral prefrontal cortex. After the CBT 
patients exhibited activity increases in the ventromedial prefrontal cortex, an enhanced 
discrimination of emotional and neutral items in the amygdala and the caudate, as well as 
greater activity in response to positive versus neutral items in the left anterior temporal lobe. 
In accordance with the afore mentioned assumptions these neural changes may reflect 
increased engagement of processes that are involved in modulating responses to emotional 
stimuli. Furthermore, some of the identified pre-treatment differences between the two 
groups were predictive of the patients’ treatment response. These included the hyperactivity 
in the ventromedial prefrontal cortex as well as the negativity bias in the left anterior 
temporal lobe and in the right dorsolateral prefrontal cortex. 
 
CBT involves at least 3 broad treatment goals: 
i. challenge patients‘ current way of coping with stressful events and problematic 
interpersonal relationship, 
attempts to enhance problem-solving capacities.  
Neuropsychological studies show that working memory, cognitive flexibility and 
other executive funtioning processes are involved. This brings the dorsolateral 
prefrontal cortex (dlPFC) and the hippocampus (Hc) into play and makes them 
potential targets of CBT.  
ii. modify patients‘ perspectives about themselves and their relationships.  
Neuroimaging studies suggest that cortical midline structure, such as the ventral 
(vACC) and dorsal (dACC) anterior cingulate cortex, the ventralmedial (vmPFC) and 
dorsomedial (dmPFC) prefrontal cortex, the posterior cingulate cortex (pCC) are 
involved in self-related information processing. These brain areas are potential targets 
of CBT. 
iii. assist patients in regulating distressing emotional states. CBT may impact brain 
functions associated with emotional processing, such as insular cortex (vlns), the 
amygdala (Am), the ventral and dorsal anterior cingulate cortex (vACC, dACC), 
the dorsolateral prefrontal cortex (dlPFC), the ventro-medial prefrontal cortex 
(vmPFC). 
Table 1. Mechanisms of change – mediators of outcome 
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The mediating role of cognitive changes  
The assumption of cognitive theory is that depressive symptoms change while the patients 
change their beliefs and the way they process information [65]. Indeed, besides neural 
changes that seem to reflect an enhanced cognitive control over emotions after CBT, it has 
been shown that the habitual tendency to ruminate decreases over the course of a CBT – a 
finding that fits well to the results concerning the neural level [66]. However, this was 
nothing unique to CBT but has also been found to occur during a Mindfulness-Based 
Cognitive Therapy (MBCT) [66]. Moreover, it has been shown that during CBT as well as 
during ADM automatic negative thoughts decrease and this reduction in turn has been 
associated with overall clinical improvement, so as to patients who did not benefit from 
either intervention showed significantly less change on cognitive measures [67-68]. Further 
studies have confirmed that reductions in negative cognitions are not only present in CBT 
but that different CBT treatment components are comparably effective in reducing negative 
cognitions. For instance, cognitive therapy and behavioral activation produce similar 
reductions in negative cognitions [20, 69]. According to Simons and colleagues these results 
suggests that cognitive change can be understood as a part of improvement rather than as 
the primary cause of improvement [68].To clarify the direction of effects DeRubeis and 
colleagues obtained depression severity scores as well as different measures of cognition not 
only in the beginning and in the end of a CBT and an ADM but also repeatedly during 
treatment admission [70]. The authors found that while cognitive change from pretreatment 
to midtreatment predicted change in depression from midtreatment to posttreatment in the 
CBT group, this was not the case in the ADM group. Thus, the authors concluded that 
cognitive changes indeed play a mediating role in CBT but not in ADM. Further support for 
the importance of cognitive changes in CBT comes from a more recent study in which it has 
been shown that among those patients who responded to a CBT both the development of 
CBT coping skills as well as in-session evidence of the independent use of these skills 
predicted a lower risk of relapse in the year following treatment [71]. Thus, it can be 
concluded that the development and use of CBT coping skills play an important role in 
relapse prevention. Similarly, Zindel Segal and colleagues [72] examined whether mood-
linked changes in dysfunctional thinking following a sad mood induction predict relapse in 
depressed patients in remission. Therefore, patients were first randomly assigned to either 
ADM or CBT. Afterwards, patients who achieved remission underwent a sad mood 
induction and were then observed and repeatedly examined in the following 18 months. 
The authors reported two main findings: First, patients who recovered through ADM 
showed greater cognitive reactivity in response to a negative mood induction than those 
who recovered through CBT. Second, the magnitude of cognitive reactivity associated with 
the negative mood induction significantly predicted relapse over the subsequent 18 months 
– independently of the type of prior treatment.   
Whereas changes in more superficial cognitions (i.e., automatic thoughts) seems to be a 
result of different interventions, changes in more basic cognitions, for example attributional 
style or dysfunctional beliefs, seem to be significantly larger  and thus more unique to CBT 
[73]. Furthermore, it has been demonstrated that a change of these more stable information-
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processing proclivities does mediate the smaller rate of relapse following a CBT [73-74]. 
Thereby it proved to be important that patients do become less extreme in their information-
processing instead of becoming unrealistically positive as the latter is also associated with a 
greater risk to relapse [74-75].  
Another study that examined the mediating role of cognitive changes in the efficacy of CBT 
highlighted that many patients experience so-called “sudden gains” during a cognitive 
behavioral intervention [76]. Sudden gains refer to large symptom improvements in a single 
between-session interval that account for about fifty percent of these patients total 
improvement. These sudden gains were associated with a lower depression-level 
posttreatment and at an 18-month follow-up. Tang and DeRubeis [76] found that these 
sudden gains were preceded by considerable cognitive changes in the therapy session that 
has taken place immediately before the sudden gains and presume that these changes 
triggered the sudden gains. Furthermore, an improvement of the therapeutic alliance as well 
as additional cognitive changes followed in the therapy session immediately after the 
sudden gains. So, it can be assumed that considerable cognitive changes during one CBT 
session may lead to sudden gains that can be understood as the beginning of an upward 
spiral. Interestingly, one variable that also seems to predict later treatment outcome is the 
early improvement in the course of a CBT [77].  
4. New developments in the CBT for depression 
Within the last years there have been made some attempts to increase the access to CBT 
resulting in new types of CBT treatments as for example online- and telephone based 
treatments. Given the high stigmatization that is associated with psychiatric disorders and 
the therapeutic interventions for these disorders on the one hand and the increasing use of 
the internet and online programs on the other hand this development seems nothing but 
logical. Besides the easy accessibility and the potential to offer an approach in a non-
stigmatizing environment there are some further advantages in conducting computerized 
CBT (cCBT). For instance, cCBT has the capacity to deliver structured input consistently 
with precision and is associated with comparably low costs [78]. Moreover, it has been 
shown that discontinuation of treatment is a problem that seems to be associated with face-
to-face therapy [79]. According to some estimations about 47% of patients may drop out of 
psychotherapy [80]. Besides the already mentioned stigmatization limited time and the 
travel that is required to see a therapist might be barriers to the face-to-face treatment.   
Before we summarize the findings concerning the efficacy of cCBT we would like to 
mention that computers and the internet can not only be used as an alternative to the 
traditional form of CBT but also as an adjunct to the individual contact with a therapist [78]: 
For example a computer can be used as a tool for screening or diagnosis and information 
can be provided either in written or in audio/video formats. Furthermore, structured self-
help programs can be provided online whereby situations can be easily simulated and 
graded exposure in highly controlled conditions is possible. Besides that the patient and the 
therapist may communicate via emails, chats or forums either for therapeutic or 
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administrative purposes. So, it can be concluded that the use of computers and the internet 
has the potential to enrich the therapeutic possibilities of the traditional face-to-face 
communication considerably. 
However, what do we know concerning these new developments and especially concerning 
their efficacy? There are many cCBT programs developed for the treatment of depression 
named for example ‘Colour Your Life’ or ‘Beating the Blues’ and it has been shown that they 
are effective in the treatment of depression [81]. Foroushani and colleagues conducted a 
meta-review in which they included twelve systematic reviews covering results concerning 
the effectiveness of cCBT for mild to moderate depression [78]. This meta-review clarifies 
that while for single cCBT programs, as for example for ‘ODIN’, there is not enough data 
with good quality to conclude that they are really effective other cCBTs for depression, as 
for example ‘MoodGYM’, ‘Beating the Blues’, and ‘Colour Your Life’, have proven to be 
effective in reducing symptoms of depression. Looking at effect sizes that are reported for 
cCBT there are greater differences. Concerning to a review by Griffiths, Farrer and 
Christensten it ranges over different studies between 0.42 to 0.65 for cCBT interventions that 
included clinically depressed patients [81]. It has been reported that some cCBT packages 
seem to be more effective than treatment as usual (TAU), equally or less effective than 
bibliotherapy and no less effective than therapist-led CBT [78]. Even self-help internet 
interventions have been shown to reduce symptoms although this effect was smaller for 
depression than for anxiety disorders [78]. Furthermore, studies have indicated that it 
doesn’t seem to be necessary that cCBT interventions are supported by mental health 
professionals [81] even though there is evidence that the provision of therapist support or 
the ongoing contact with users during an intervention seems to increase the effect of cCBT 
[82-83]. Even though it can be said that these first results seem to be quite promising the 
evidence indicating the effectiveness of cCBT is still limited so far and further randomized 
controlled trials are required. Another finding in the context of cCBT is that, as one would 
expect, cCBT reduces therapist time. However, to date it cannot be concluded that cCBT has 
superior effectiveness as compared to other forms of CBT because the therapist time of an 
intervention is only one variable amongst a number of variables that determine the cost-
effectiveness.  
Besides cCBT CBT offered through the telephone (tCBT) has also been shown to have 
positive effects on depression [84]. Moreover, in a randomized controlled trial Mohr and 
colleagues compared a 16-week tCBT program with 16 weeks of a supportive emotion-
focused therapy also administered via telephone and found that improvements over 
treatment were significantly greater for tCBT than for the telephone-administered 
supportive intervention [85]. Furthermore, the treatment gains were still present during 12-
month follow-up even though the differences between the two treatments were no longer 
evident. This study highlights that there is a specific effect of telephone-administered CBT 
that goes beyond the nonspecific effects of a supportive telephone-based intervention. In a 
more recent study it has been examined how tCBT performs as compared to face-to-face 
CBT with respect to attrition and symptom reduction [86]. Thereby, it has been shown that 
while both treatments were associated with a significant symptom reduction posttreatment, 
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with CBT not being noteworthy superior to tCBT, more patients completed tCBT as 
compared to traditional CBT. However, even though all participants remained significantly 
less depressed at 6-month follow-up as compared to baseline participants receiving 
traditional CBT were significantly less depressed than participants receiving tCBT. Thus, the 
authors conclude that even though tCBT improves adherence compared with traditional 
CBT this might go at the cost of some increased risk of poorer maintenance of gains after the 
time of treatment. Further findings suggest that a telephone-administered CBT might not 
only be helpful as stand-alone therapy but also as an adjunct to pharmacotherapy. In a 
randomized trial with 393 depressed patients Ludman and colleagues evaluated usual care 
versus tCBT plus care management for primary care patients who were beginning an 
antidepressant treatment and highlighted that a brief, structured, telephone-administered 
CBT program can improve clinical outcomes for the majority of patients beginning 
antidepressant treatment in primary care [87]. 
So far there is only very little knowledge concerning moderator variables of cCBT. One 
study that investigated whether factors that are prognostic of depression outcome generally 
do also predict response to online CBT in a sample of depressed patients has been 
conducted by Button and colleagues [88]. In this study it has been shown that marital status 
as well as pretreatment severity predicted treatment response of the patients. Thereby, 
patients who were separated, widowed, or divorced showed a greater symptom reduction 
following the online CBT than did married patients. Having in mind earlier studies that 
repeatedly showed that in face-to-face CBT married patients have a better prognosis than 
unmarried individuals [37-38] this finding may indicate that online CBT is particularly 
beneficial for separated, widowed, and divorced patients and thus be a first hint on a 
moderating variable. However, this finding definitely requires replication as it is based on 
only one single study so far. Another finding of this study was that patients who were more 
severely depressed also displayed a superior treatment-derived benefit – a result that has 
already been reported in an earlier study concerning therapist-delivered internet 
psychotherapy for depression [89]. Furthermore, the authors found weak evidence that 
treatment effectiveness diminished with an increasing number of recent adverse life events. 
In contrast, age, educational level, and history of depression did not predict treatment 
response. Another variable that was assumed to possibly have the potential to moderate the 
effect of a cCBT and that has also been examined is the chronicity of depression [90]. 
However, no significant difference between chronic patients and non-chronic patients has 
been found in treatment outcome. In another randomized trial three hundred and three 
depressed patients were randomly assigned to either an unsupported online cCBT, a 
treatment as usual (TAU), or the combination of cCBT and TAU and demographic, clinical, 
cognitive, and short-term improvement variables have been assessed as potential moderator 
variables [91]. It could be shown that patients with higher levels of extreme (positive) 
responding as assessed by the Dysfunctional Attitude Scale-Form A benefited more from 
cCBT as compared to TAU, whereas patients who had a parental psychiatric history or the 
diagnosis of a major depressive disorder showed a better treatment response in cCBT and 
TAU as compared to TAU alone. Irrespective of treatment type current employment, low 
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pretreatment illness severity as well as short-term improvement on clinical variables 
predicted a greater treatment-benefit.      
Concerning mediating mechanisms of change in cCBT there are even les studies than 
concerning possible moderator variables. One study that evaluated treatment specificity and 
potential mediators of two online therapies for depressive symptoms included 263 
depressed patients who were randomly assigned to either online CBT, online problem-
solving Therapy (PST) or a waiting list control group [92]. Interestingly, no differing 
mechanisms of change have been found: Dysfunctional attitudes, worrying, a negative 
problem orientation, and perceived control all played a mediating role in online CBT as well 
as in online PST. Hence, the authors conclude that irrespective of the theoretical background 
of the therapy the psychological processes that lead to symptom reduction seem to be 
comparable.  
5. Main components of the cognitive behavioral therapy for bipolar 
disorders 
In contrast to unipolar depressive disorders bipolar disorders have long been regarded as 
purely biological-psychiatric disorders that can only be treated with medication. Therefore, 
psychotherapy has only had a supporting role, thought to be only helpful in encouraging 
medication adherence [93]. Due to the insight in the fundamental role of psychosocial 
factors in the onset and course of bipolar disorders [94-95] a more biopsychosocial 
explanatory model has only developed during the last decades and has brought about 
cognitive behavioral treatment approaches among other psychosocial interventions [96-98].   
As in the treatment of other psychiatric disorders the first step of a successful CBT for 
bipolar disorders is the development of a good and sustainable therapeutic relationship. On 
the basis of this relationship psychoeducational sessions can be offered and concrete and 
achievable therapy goals can be formulated with the patient. Within the psychoeducation 
the therapist and the patient develop knowledge concerning factors that initiate and 
maintain bipolar symptomatology by building on the individual experiences of the patient. 
Thus, the role of genetic, biological, psychological and social factors in the development and 
maintenance of the illness are discussed and a vulnerability-stress-model is developed. 
Furthermore, the patient and the therapist deduce the intercorrelation of mood, behavior 
and thinking from the individual experiences of the patient so that a rationale of the bipolar 
disorder as well as a treatment rationale can be developed. The main goal of the CBT for 
bipolar disorders is to stop the downward spiral leading to depressive episodes as well as to 
stop the upward spiral leading to (hypo-)manic episodes. Therefore, within the 
psychoeducational sessions the symptomatology that is specific for depressive or (hypo-) 
manic episodes respectively is discussed. Furthermore, therapists focus on the course and 
prognosis of the illness, the role of risk factors and protective factors, as well as individual 
warning signs and prodromal symptoms. Moreover, medical and psychotherapeutic 
treatment opportunities are discussed.  
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A further essential element of the CBT for bipolar disorders is a detailed analysis of the 
behavior and the preconditions that might have led to former affective episodes. On the 
basis of this knowledge potential triggers (that might be either negative or positive), early 
warning symptoms and prodromal symptoms as well as successful and unsuccessful coping 
strategies can be identified.  
On this background it can be made out which further contents should be focused in the 
remaining therapy sessions. Thereby it might for example be useful to focus on the structure 
of the everyday life of the patient: While during depressive episodes many patients tend to 
withdraw and to reduce their daily activities to a minimum, during (hypo-)manic episodes 
many patients tend to overload their schedule excessively. It may also be useful to 
concentrate on problem solving or social competence skills, or on dysfunctional attitudes. 
Working on dysfunctional attitudes also comprises looking at cognitive errors that are 
characteristic for either depression (as for example all-or-nothing-thinking, 
overgeneralization, catastrophizing or mental filters) or (hypo-)mania (as for example 
positive fortune-telling, overevaluation of immediate satisfaction or the misinterpretation of 
others’ intention) and to comprehend these typical errors by looking at individual 
experiences of the patient [99]. To overcome these typical cognitive errors associated with 
depressive or (hypo-)manic mood states strategies can be helpful that are also used in the 
treatment of depression as for example the Socratic dialogue or behavioral experiments and 
reality testing in order to reach cognitive restructuring.  
A further component of the CBT for bipolar disorders is to keep a mood diary during the 
therapy. This is a good opportunity to collect information and to develop the ability to 
differentiate between normal and harmless mood swings or fluctuations in the sleeping 
pattern and first symptoms that are due to the illness [100]. With the aid of a better ability to 
differentiate between pathological and normal changes in mood and sleeping pattern the 
patient is able to recognize potential triggers and first symptoms of new episodes in time 
and to make use of promising coping strategies [101-102]. Coping strategies for depressive 
mood states comprise for example behavioral activation whereas the strategies of stimulus 
control and anti-impulsiveness are useful in (hypo-)manic mood states. It can be 
summarized that the main goal of CBT for bipolar disorder is to make the patients 
specialists concerning their own illness and to enable them to behave in a way that prevents 
the occurrence of prodromal symptoms or to counteract occurring prodromal symptoms in 
time.  
In some cases it is also necessary to involve family members in the therapy of bipolar 
patients. Family members may for example be helpful to identify early warning symptoms 
as some patients are not able to identify them all alone. Furthermore, in some cases it needs 
to be discussed how family members can give feedback and offer help to the patient if they 
have the impression than the patient is developing a new affective episode. On the other 
hand it is often necessary to clarify and to illustrate that not all mood changes are 
necessarily indicators for the beginning of a further affective episode but are normal to a 
certain extent.   
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As in the case of unipolar depression it is indispensable to address the issue of probable 
future crises during the last therapy sessions and to reflect possibilities that may help the 
patient to get along self-directed. Concrete emergency schedules should be developed for 
depressive symptoms as well as for (hypo-)manic symptoms. Furthermore, it is helpful to 
fade out therapeutic contacts slowly – just as in unipolar depression. 
6. Effectiveness and efficacy of cognitive behavioral therapy in the 
treatment of bipolar disorders 
During the last twenty years randomized controlled trials have shown that CBT for bipolar 
disorders is not only helpful to encourage medication adherence [93] but as an adjunct to 
medication also to reduce symptom severity, to accelerate stabilization, to delay relapses, 
and to improve the level of functioning [e.g., 103, 104-105]. In a recent systematic review 
Miklowitz and Scott included all randomized trials of adjunctive therapy for bipolar 
disorders that have been published between 1980 and 2008 [106]. While many of these 
studies examined the effectiveness of other psychosocial interventions (e.g., 
psychoeducation, systematic care management, family focused therapy) more than ten 
studies that have been included have specifically examined the effectiveness and efficacy of 
CBT for bipolar disorders. Even though Miklowitz and Scott point out that all these studies 
differ concerning many methodological issues (e.g., different kinds of CBT interventions, 
different sample characteristics) a great portion of these studies revealed that CBT is 
superior to routine care (i.e., mood stabilizers plus outpatient support) with respect to many 
outcome variables as for example the number of relapses, the improvement of social 
adjustment and the improvement of coping strategies to manage prodromal symptoms. 
Furthermore, patients who receive CBT seem to have less psychiatric admissions or days in 
an affective episode. This seems to be not only the case during the time of treatment but has 
also been shown for longer follow-up periods (e.g., 30 months). Interestingly, over a 30-
month follow-up CBT has not only been superior to TAU concerning the clinical outcome 
variables but also concerning the costs that have been associated with the respective 
treatment form. 
However, most studies that have been conducted to examine the efficacy of CBT for bipolar 
disorders have compared the effects of CBT against the effects of a TAU condition. Thereby, 
in most cases the CBT group received the CBT in addition to what has been referred to as 
TAU (e.g., medication which is associated with regular visits to the psychiatrist). Hence, the 
patients allocated to the CBT group received more attention and support than patients who 
have been allocated to the control group in these studies. To control for the effects of the 
surplus in attention and support that has been associated with the CBT groups in former 
studies Meyer and Hautzinger conducted a randomized controlled trial in which they 
compared CBT to a supportive therapy (ST) [107]. The authors found no differences between 
the two treatment conditions with respect to relapse rates. Thus, it can be assumed that 
certain characteristics that are shared by many psychosocial interventions as for example 
providing information or systematic mood monitoring might explain the effects of different 
kinds of treatments for bipolar disorders. This finding fits to a meta-analysis conducted by 
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Lynch and colleagues in which amongst others the effectiveness of CBT for bipolar 
disorders has been examined by pooling data from published trials of CBT that used 
controls for non-specific effects of intervention [108]. Furthermore, trials of effectiveness 
against relapse were also pooled if they compared CBT to TAU. In this analysis CBT proved 
to be ineffective in reducing relapse in bipolar disorder. The authors conclude that based on 
the present data CBT does not seem to be an effective treatment strategy for relapse-
prevention in bipolar disorder. Based on these findings Meyer and Hautzinger summarize 
that there is not much evidence for specific effects of CBT for bipolar disorders. Therefore, 
they suggest that future research should focus on matching patients to treatments, that is on 
examining possible moderator variables of CBT for bipolar disorders.        
7. Mediators and moderators of treatment effects of CBT for bipolar 
disorder 
While there are many studies dealing with moderators and mediators of CBT for depression 
studies examining the moderators and mediating mechanisms of CBT for bipolar disorders 
have rarely been conducted. However, there are first hints that patients with specific 
characteristics seem to benefit less respectively more from CBT than do other patients.  
Some patient characteristics with unclear status: Prognostic factors or moderator variables for the 
response to CBT for bipolar disorders? 
Lam et al. randomized over one hundred patients to either CBT or a control group and 
examined whether patients who score highly on the so-called Sense of Hyper-Positive Self 
Scale (SHPSS) do respond to CBT as well as other patients do [109]. The SHPSS measures to 
what extent patients suffering from a bipolar disorder value themselves and assume that they 
possess personal attributes that are associated with a state of being ‘mildly high’ (e.g., 
dynamism, productiveness). As expected the authors found that patients with high scores on 
the SHPSS had a significantly higher rate of relapse after controlling for other clinical variables 
that are relevant in this context. Another variable that seems to play a role in the 
responsiveness to CBT is the level of activation the patients display: In this context it has been 
revealed that patients who show heightened and more volatile activation scale scores show a 
worse response to CBT than patients who show a contrary pattern [110]. Furthermore, it seems 
as if patients with fewer than twelve previous affective episodes benefit more from CBT with 
regard to relapse that patients with more affective episodes [111]. 
The mediating role of dysfunctional attitudes and further potential mediators 
Ball and colleagues conducted a randomized controlled trial of schema-focused CBT that 
made, besides the typical CBT techniques, use of emotive therapy techniques as for example 
imagery or reliving of early experiences [112]. In this study fifty-two bipolar patients have 
been randomized to either CBT plus mood stabilizers or treatment as usual (TAU) plus 
mood stabilizers. It has not only been revealed that patients who received CBT had lower 
depression scores at posttreatment but also that they displayed less dysfunctional attitudes 
than patients who were allocated to TAU. Furthermore, patients who received CBT seemed 
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to show a greater time to depressive relapse as compared to the TAU patients (however, 
statistically seen this was only significant on a trend level). In the one-year follow-up CBT 
patients showed a trend toward lower manic symptoms and improved behavioral self-
control. Moreover, the change of the severity of illness status from baseline to 18-months 
follow-up changed more within the CBT group as compared to the TAU group. Even 
though some methodological issues can be brought up against this study (for example it 
remains unclear if schema-focused CBT has any advantages in the treatment of bipolar 
disorders as compared to ‘pure’ CBT) this study suggests that one mediating mechanism of 
CBT for bipolar disorder may lay in the change of dysfunctional attitudes. This suggestion 
finds support in a study by Zaretsky and colleagues in which seventy-nine patients 
suffering from bipolar disorder have been randomized to either psychoeducation plus CBT 
or a short course of psychoeducation (PE) alone [113]. While the groups did not differ 
concerning hospitalization rates, medication adherence, psychosocial functioning, or mental 
health use, it has been shown that patients who received CBT in addition to PE experienced 
50% fewer days of depressed mood over the course of one year and needed antidepressant 
increases less frequently than patients allocated to PE. Furthermore, dysfunctional attitudes 
decreased significantly more in the CBT group than in the PE group, suggesting that this 
indeed might be a mediating variable. Another variable that has also been shown to change 
during CBT is the coping with prodromal symptoms [114]. Thus, it could be assumed that 
this might also be a mediating variable for the effectiveness of CBT. However, this 
association has never been specifically examined.   
In contrast to the field of unipolar depression there are, to our knowledge, no studies 
concerning neural correlates of treatment response in bipolar disorders. Thus, one can only 
speculate that prefrontal and subcortical areas and networks that are involved in emotion 
regulation might play a mediating role in CBT for bipolar disorders.  
Due to the lack of studies concerning moderators and mediators of CBT for bipolar 
disorders Miklowitz and Scott list a number of variables that “could provide viable 
explanations for the effectiveness of various forms of psychotherapy” [106]. Amongst other 
variables they list for example acquiring emotional self-regulation skills, improving social 
skills, enhancing medication adherence, stabilizing sleep/wake cycles and other daily 
routines, and improving the ability to identify and intervene early with relapses.    
8. New developments in the CBT for bipolar disorders 
While there is a growing body of research concerning cCBT for depression these new 
developments have hardly been used in the treatment of bipolar disorders. In 2007 Barnes 
and colleagues described an internet-based disease management platform that has been 
developed by Sentiens, a mental health service provider in Perth (Australia), called 
‘Recovery Road’ (RR) [115-116]. This platform enables patients and their treating clinicians 
to keep contact by the use of asynchronous messaging. Furthermore, patients and clinicians 
are provided with self-report monitoring tools including different online mental health, 
medication adherence, and quality-of-life questionnaires so that they receive immediate 
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feedback on progress, medication adherence and risk of relapse. Moreover, users have 
access to a one-year relapse prevention program for bipolar disorders (or psychosocial 
treatments for other mental illnesses) including ten sessions of CBT that has been developed 
by Barnes. As far as we know, the results of the randomized controlled trial that has been 
conducted by Barnes and colleagues to evaluate this cCBT program for bipolar disorder 
have not been published so far. Therefore, it has to be awaited if cCBT can also be helpful in 
the treatment of bipolar disorder.  
9. Gaps of knowledge and future directions 
As we have seen compared to the field of bipolar disorders there are many studies 
examining potential moderator and mediator variables of CBT for depression. However, in 
some cases there are contradictory findings that do not allow drawing definite conclusions. 
For example it is still not clear whether more severe and complicated patients do better or 
worse in CBT treatment as compared to patients with a less severe symptomatic. It may be 
that the heterogeneity of the findings concerning this specific patient characteristic is at least 
in part due to a different extent of therapists’ expertise. Therefore, in future studies 
concerning the outcome of CBT in depression, we recommend to control for the expertise 
status of therapists, to elucidate the role of illness severity and comorbid personality 
disorders. In this context it seems important to mention a study that has been conducted by 
Strunk and colleagues [117]. In this study the therapists’ competence has been rated and the 
authors found that the adequacy of therapists’ delivery of the treatment is predictive for 
symptom change early in treatment. Furthermore, Strunk et al. investigated whether 
therapists’ competence is more important to patients with specific complicating features and 
found that competence seems to be more important to patients who were characterized by 
higher anxiety, an earlier age of onset, and who suffered from a chronic form of depression 
as compared to patients without these characteristics. However, patients with a comorbid 
personality disorder did not have a greater benefit in dependence of the therapists’ 
competence as compared to those patients who didn’t meet criteria for a personality 
disorder. This study impressively illustrates that the expertise of the therapists may have a 
strong influence on the findings concerning potential moderator variables of CBT. 
Therefore, it needs to be taken into account in future studies. 
An even more far-reaching problem in the context of studies searching for potential 
moderator variables of CBT for depression is that in many cases it is not strictly 
distinguished between moderator variables on one side and prognostic factors on the other. 
Thus, many studies only examine whether a variable predicts the treatment response to CBT 
whereas studies also including other psychosocial interventions in addition to CBT to 
examine the differential prognostic value of potential moderator variables are rather limited. 
Therefore, it seems necessary to disentangle the meaning of ‘predictors/prognostic factors’ 
versus ‘moderator variables’ and to clearly carve out whether a variable is one or the other. 
For example, based on findings that demonstrate that those patients benefit most from CBT 
who show an increased emotional reactivity pretreatment and who are not able to engage 
regulatory structures pretreatment, Siegle and colleagues propose that the presence of 
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emotion regulation deficits, which are targeted in CBT, may be the key to recovery with this 
specific intervention. Even though this assumption seems plausible, up till now it is not 
clear whether this prediction is specific to CBT. It is also possible that the same pattern could 
be found for other psychosocial interventions, as for example for IPT. To be able to decide 
what treatment to select for which patient it is necessary to go beyond the investigation of 
prognostic factors and to examine moderating variables.  
A structurally related argument can be brought up against some studies investigating 
mediator variables. Strictly speaking, some studies that examine mediating mechanisms do 
not clearly distinguish variables mediating the response to CBT or variables being part of 
improvement rather than being a cause of improvement. To disentangle this more clearly, it 
would be required to assess the mediating as well as the outcome variable not only at study 
entry and the end of the study but also repeatedly during the therapy to make sure that the 
change of the mediator variable really precedes the change of the outcome variable and to 
rule out reverse causality. 
While more and especially more carefully designed studies are already required concerning 
moderating and mediating variables of face-to-face CBT this is even more the case for the 
relatively new developments of cCBT and tCBT. Future studies should shed light on the 
question if cCBT and tCBT might be helpful especially for those patients who do not benefit 
as much from traditional CBT as do other patients. If so, these new developments could be 
routinely implemented into the health care systems and be provided especially to those 
patients who are not addressed successfully so far. The examination of the therapeutic 
usefulness of technical devices such as smart phones, tablet pc and apps will be another area 
of future research. 
Even though there are some promising results concerning the effectiveness and efficacy of 
CBT for bipolar disorders until now it is not clear whether these findings can be traced back 
to active factors that are specific to CBT or whether these are due to rather unspecific factors 
that are associated with any kind of psychosocial treatment and even with supportive 
interventions. Furthermore, to date there is hardly any knowledge concerning moderator 
variables of the response to CBT for bipolar disorders and concerning mediating 
mechanisms. However, knowing moderator variables means to have a basis for choosing the 
best treatment for a given patient and thus is indispensable to improve our treatment 
assignments as well as to reduce our health care costs. Therefore, it seems necessary to 
broaden our knowledge in this context. The same holds true for mediating variables as these 
provide us with an answer to the question how CBT works and thus not only allow to 
identify mechanisms of change within the patient but also to identify active therapy 
ingredients in the treatment process. This in turn can be used to develop even more 
efficacious forms of therapy. 
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